Patent · US Active

Functional segregated telodendrimers and nanocarriers and methods of making and using same

US10967003B2 · kind B2 · utility

1Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 5, 2019
Grant dateApr 6, 2021
Priority date
Expiry dateNov 5, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are multiply functional telodendrimers. The telodendrimers can be used for combination drug delivery. The telodendrimers may have one or more crosslinking groups (e.g., reversible photocrosslinking groups). The telodendrimers can aggregate to form nanocarriers. Cargo such as combinations of drugs, imaging probes, and other materials may be sequestered in the core of the aggregates via non-covalent or covalent interactions with the telodendrimers. Such nanocarriers may be used in drug delivery applications and imaging applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.